Copyright
©The Author(s) 2023.
World J Hepatol. Nov 27, 2023; 15(11): 1174-1187
Published online Nov 27, 2023. doi: 10.4254/wjh.v15.i11.1174
Published online Nov 27, 2023. doi: 10.4254/wjh.v15.i11.1174
Score | Equation | Cut-off | Predicted survival rate |
CTP | Serum bilirubin, serum albumin, INR, ascites, HE | - | - |
MELD | 9.57 × log (creatinine) + 3.78 × log (total bilirubin) + 11.2 × log (INR) + 6.43 | - | - |
Zeitoun index | Ascites scorea × 0.75 + Child-Pugh score × 0.28 + age × 0.037 + creatinine × 0.0036 | 5.4 (range from 3.4 to 9.1) | At 5 yr; ≤ 5.4: 95%; > 5.4: 65% |
New Clichy score | 0.95 × ascites score + 0.35 × CTP score + 0.047 × age + 0.0045 × serum creatinine + 2.2 × type IIIbb—2.6 | 5.1 (range from 2.0 to 9.7) | At 5 yr; < 5.1: 100%; ≥ 5.1: 65% |
Rotterdam BCS index | 1.27 × encephalopathy + 1.04 × ascites + 0.72 × prothrombin time + 0.004 × bilirubin | Bilirubin; class I: 0–1.1; class II: 1.1–1.5; class III: ≥ 1.5 (range from 0.02 to 4.03) | At 5 yr; class I: 89%; class II: 74%; class III: 42% |
TIPS-BCS index | Age (yr) × 0.08 + bilirubin (mg/dL) × 0.16 + INR × 0.63 | 7 | 1-yr OLT-free survival, ≤ 7: 95%; > 7: 12% |
BCS-intervention-free survival prognostic score | Ascites (yes = 1, no = 0) × 1.675 + ln creatinine (μmol/L) × 0.613 + ln bilirubin (μmol/L) × 0.440 | Interval 1: ≤ 5; interval 2: 5-6; interval 3: ≥ 6 | Intervention-free survival interval 1: 78.3%, interval 2: 27.8%; interval 3: 6.8% |
AIIMS-HVOTO score | 1.2 × response to therapy + 0.8 × child class) | Score: < 3; 3-4; > 4 | % yr survival score ≤ 3: 92%; score 3-4: 79%; score > 4: 39% |
- Citation: Samanta A, Sen Sarma M, Yadav R. Budd-Chiari syndrome in children: Challenges and outcome. World J Hepatol 2023; 15(11): 1174-1187
- URL: https://www.wjgnet.com/1948-5182/full/v15/i11/1174.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i11.1174